Apyx Medical Statistics

Total Valuation

Apyx Medical has a market cap or net worth of $188.43 million. The enterprise value is $196.76 million.

Market Cap	188.43M
Enterprise Value	196.76M

Important Dates

The next estimated earnings date is Thursday, August 6, 2026, after market close.

Earnings Date	Aug 6, 2026
Ex-Dividend Date	n/a

Share Statistics

Apyx Medical has 41.87 million shares outstanding. The number of shares has increased by 12.91% in one year.

Current Share Class	41.87M
Shares Outstanding	41.87M
Shares Change (YoY)	+12.91%
Shares Change (QoQ)	+3.74%
Owned by Insiders (%)	13.63%
Owned by Institutions (%)	34.96%
Float	29.94M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	3.37
Forward PS	3.11
PB Ratio	14.68
P/TBV Ratio	14.68
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	3.52
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 5.80, with a Debt / Equity ratio of 3.02.

Current Ratio	5.80
Quick Ratio	4.65
Debt / Equity	3.02
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-0.77

Financial Efficiency

Return on equity (ROE) is -76.49% and return on invested capital (ROIC) is -5.27%.

Return on Equity (ROE)	-76.49%
Return on Assets (ROA)	-4.37%
Return on Invested Capital (ROIC)	-5.27%
Return on Capital Employed (ROCE)	-8.04%
Weighted Average Cost of Capital (WACC)	11.77%
Revenue Per Employee	$272,702
Profits Per Employee	-$44,727
Employee Count	205
Asset Turnover	0.91
Inventory Turnover	2.39

Taxes

In the past 12 months, Apyx Medical has paid $364,000 in taxes.

Income Tax	364,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +136.84% in the last 52 weeks. The beta is 1.39, so Apyx Medical's price volatility has been higher than the market average.

Beta (5Y)	1.39
52-Week Price Change	+136.84%
50-Day Moving Average	3.97
200-Day Moving Average	3.60
Relative Strength Index (RSI)	57.54
Average Volume (20 Days)	167,880

Short Selling Information

The latest short interest is 211,948, so 0.51% of the outstanding shares have been sold short.

Short Interest	211,948
Short Previous Month	167,446
Short % of Shares Out	0.51%
Short % of Float	0.71%
Short Ratio (days to cover)	0.92

Income Statement

In the last 12 months, Apyx Medical had revenue of $55.90 million and -$9.17 million in losses. Loss per share was -$0.22.

Revenue	55.90M
Gross Profit	35.30M
Operating Income	-4.31M
Pretax Income	-8.71M
Net Income	-9.17M
EBITDA	-3.59M
EBIT	-4.31M
Loss Per Share	-$0.22

Full Income Statement

Balance Sheet

The company has $31.14 million in cash and $39.46 million in debt, giving a net cash position of -$8.32 million or -$0.20 per share.

Cash & Cash Equivalents	31.14M
Total Debt	39.46M
Net Cash	-8.32M
Net Cash Per Share	-$0.20
Equity (Book Value)	13.09M
Book Value Per Share	0.31
Working Capital	45.35M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$7.87 million and capital expenditures -$1.12 million, giving a free cash flow of -$8.99 million.

Operating Cash Flow	-7.87M
Capital Expenditures	-1.12M
Depreciation & Amortization	719,000
Net Borrowing	-20,000
Free Cash Flow	-8.99M
FCF Per Share	-$0.21

Full Cash Flow Statement

Margins

Gross margin is 63.15%, with operating and profit margins of -7.70% and -16.40%.

Gross Margin	63.15%
Operating Margin	-7.70%
Pretax Margin	-15.58%
Profit Margin	-16.40%
EBITDA Margin	-6.42%
EBIT Margin	-7.70%
FCF Margin	n/a

Dividends & Yields

Apyx Medical does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-12.91%
Shareholder Yield	-12.91%
Earnings Yield	-4.87%
FCF Yield	-4.77%

Analyst Forecast

The average price target for Apyx Medical is $6.50, which is 44.44% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$6.50
Price Target Difference	44.44%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (3Y)	13.43%
EPS Growth Forecast (3Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on January 6, 1994. It was a reverse split with a ratio of 1:15.

Last Split Date	Jan 6, 1994
Split Type	Reverse
Split Ratio	1:15

Scores

Apyx Medical has an Altman Z-Score of 0.77 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.77
Piotroski F-Score	4